AI Engines For more Details: Perplexity Kagi Labs You
Anti-inflammatory Properties: Cherries, especially tart cherries, contain bioactive compounds such as anthocyanins and flavonoids, which have potent anti-inflammatory effects. These compounds may help reduce inflammation in the body, alleviate symptoms of inflammatory conditions such as arthritis, gout, and muscle soreness, and promote recovery after exercise or physical activity.
Pain Relief: The anti-inflammatory and antioxidant properties of cherries may contribute to their pain-relieving effects. Some studies suggest that consuming cherries or cherry juice may help reduce joint pain and stiffness associated with osteoarthritis and rheumatoid arthritis. Tart cherry juice, in particular, has been studied for its potential to alleviate muscle pain and inflammation following strenuous exercise or intense physical activity.
Heart Health: Cherries are rich in polyphenols, including flavonoids and phenolic acids, which have been linked to cardiovascular benefits. These compounds may help lower blood pressure, reduce inflammation, improve blood vessel function, and lower cholesterol levels, thereby reducing the risk of heart disease and stroke. Regular consumption of cherries as part of a heart-healthy diet may support cardiovascular health and reduce the risk of cardiovascular events.
Sleep Improvement: Tart cherries are a natural source of melatonin, a hormone that regulates the sleep-wake cycle and promotes restful sleep. Drinking tart cherry juice or consuming tart cherries before bedtime may help improve sleep quality, duration, and efficiency in individuals with sleep disturbances or insomnia. Melatonin-rich foods like cherries may help regulate circadian rhythms and promote relaxation, leading to better sleep outcomes.
Exercise Recovery: Cherries, particularly tart cherries and tart cherry juice, have been studied for their potential role in exercise recovery and muscle repair. The anti-inflammatory and antioxidant properties of cherries may help reduce muscle soreness, inflammation, and oxidative stress following strenuous exercise. Consuming cherries or cherry juice before and after exercise may help accelerate recovery, improve muscle function, and enhance exercise performance.
Brain Health: The antioxidants and polyphenols found in cherries may have neuroprotective effects and support cognitive function and brain health. Some research suggests that regular consumption of cherries or cherry extract may help reduce the risk of age-related cognitive decline, improve memory, and protect against neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.
Digestive Health: Cherries are a good source of dietary fiber, which promotes digestive health by supporting regular bowel movements, preventing constipation, and feeding beneficial gut bacteria. The fiber content in cherries also helps promote satiety, regulate blood sugar levels, and support weight management. Including cherries as part of a fiber-rich diet can contribute to overall digestive health and well-being.
Cancer Prevention: Some studies suggest that the antioxidants and bioactive compounds in cherries may have anticancer properties and help protect against certain types of cancer. Anthocyanins, in particular, have been studied for their potential to inhibit cancer cell growth, induce apoptosis (programmed cell death), and prevent tumor formation and metastasis. However, more research is needed to fully understand the anticancer mechanisms of cherries and their potential efficacy in cancer prevention and treatment.
Rank | Probiotic | Impact |
---|---|---|
genus | Pediococcus | Reduces |
species | Akkermansia muciniphila | Increases |
species | Lacticaseibacillus rhamnosus | Reduces |
species | Lactiplantibacillus pentosus | Reduces |
species | Lactiplantibacillus plantarum | Reduces |
species | Lactobacillus acidophilus | Reduces |
species | Lactobacillus crispatus | Reduces |
species | Lactobacillus gasseri | Reduces |
species | Lactobacillus helveticus | Reduces |
species | Lactobacillus jensenii | Reduces |
species | Lactobacillus johnsonii | Reduces |
species | Lactobacillus kefiranofaciens | Reduces |
species | Latilactobacillus sakei | Reduces |
species | Lentilactobacillus kefiri | Reduces |
species | Lentilactobacillus parakefiri | Reduces |
species | Levilactobacillus brevis | Reduces |
species | Ligilactobacillus salivarius | Reduces |
species | Limosilactobacillus fermentum | Reduces |
species | Limosilactobacillus reuteri | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Acne | 0.5 | -0.5 | |
ADHD | 0.5 | -0.5 | |
Allergic Rhinitis (Hay Fever) | 0.3 | 0.5 | -0.67 |
Allergies | 0.7 | 1.5 | -1.14 |
Allergy to milk products | 0.4 | 0.9 | -1.25 |
Alopecia (Hair Loss) | 0.2 | 0.2 | |
Alzheimer's disease | 0.8 | 2 | -1.5 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 1.7 | 1.3 | 0.31 |
Ankylosing spondylitis | 1 | 1.3 | -0.3 |
Anorexia Nervosa | 0.8 | 0.8 | |
Antiphospholipid syndrome (APS) | 0.4 | 0.4 | |
Asthma | 1.3 | 1 | 0.3 |
Atherosclerosis | 1.1 | 1.1 | |
Atrial fibrillation | 1 | 0.7 | 0.43 |
Autism | 3 | 2.9 | 0.03 |
Barrett esophagus cancer | 0.2 | 0.2 | |
benign prostatic hyperplasia | 0.3 | 0.3 | |
Bipolar Disorder | 0.7 | 0.7 | |
Brain Trauma | 0.7 | 0.8 | -0.14 |
Carcinoma | 0.4 | 0.4 | |
Celiac Disease | 1.6 | 0.5 | 2.2 |
Cerebral Palsy | 0.6 | -0.6 | |
Chronic Fatigue Syndrome | 0.5 | 0.5 | 0 |
Chronic Kidney Disease | 0.5 | 0.5 | 0 |
Chronic Lyme | 0.5 | 0.5 | |
Chronic Urticaria (Hives) | 0.9 | 0.9 | |
Coagulation / Micro clot triggering bacteria | 0.7 | 0.3 | 1.33 |
Colorectal Cancer | 1.6 | 1.6 | |
Constipation | 1.3 | 1.3 | |
Coronary artery disease | 0.2 | 0.2 | |
COVID-19 | 2.7 | 0.9 | 2 |
Crohn's Disease | 2.9 | 1.8 | 0.61 |
cystic fibrosis | 0.3 | 0.3 | |
deep vein thrombosis | 0.7 | 0.3 | 1.33 |
Depression | 3.5 | 3 | 0.17 |
Eczema | 0.8 | 0.5 | 0.6 |
Endometriosis | 0.8 | 1 | -0.25 |
Epilepsy | 1.3 | 1.1 | 0.18 |
Fibromyalgia | 0.5 | -0.5 | |
Functional constipation / chronic idiopathic constipation | 1.3 | 0.5 | 1.6 |
gallstone disease (gsd) | 0.8 | 0.8 | |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 0.6 | -0.6 | |
Generalized anxiety disorder | 0.3 | 0.2 | 0.5 |
Graves' disease | 0.7 | 0.5 | 0.4 |
Hashimoto's thyroiditis | 1.3 | -1.3 | |
Histamine Issues,Mast Cell Issue, DAO Insufficiency | 1.3 | 1.3 | |
hypercholesterolemia (High Cholesterol) | 0.2 | 0.4 | -1 |
hyperglycemia | 1.1 | 1 | 0.1 |
Hyperlipidemia (High Blood Fats) | 2.2 | -2.2 | |
hypersomnia | 0.2 | 0.2 | |
hypertension (High Blood Pressure | 1.8 | 1.3 | 0.38 |
Hypoxia | 0.5 | 0.6 | -0.2 |
IgA nephropathy (IgAN) | 0.5 | 0.5 | 0 |
Inflammatory Bowel Disease | 2 | 0.9 | 1.22 |
Insomnia | 0.7 | 0.7 | |
Intracranial aneurysms | 0.5 | -0.5 | |
Irritable Bowel Syndrome | 1.9 | 1.2 | 0.58 |
Liver Cirrhosis | 2.3 | 1.3 | 0.77 |
Long COVID | 3.4 | 2.4 | 0.42 |
Lung Cancer | 0.5 | 0.5 | |
ME/CFS with IBS | |||
ME/CFS without IBS | |||
Menopause | 0.2 | 0.2 | |
Metabolic Syndrome | 3.5 | 1.7 | 1.06 |
Mood Disorders | 3.7 | 3.7 | 0 |
multiple chemical sensitivity [MCS] | 0.5 | 0.6 | -0.2 |
Multiple Sclerosis | 0.5 | 2.3 | -3.6 |
Multiple system atrophy (MSA) | 0.5 | 0.8 | -0.6 |
myasthenia gravis | 0.5 | -0.5 | |
Neuropathy (all types) | 0.5 | 0.8 | -0.6 |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 2.5 | 2.5 | |
Obesity | 2.9 | 1.3 | 1.23 |
obsessive-compulsive disorder | 1.4 | 0.5 | 1.8 |
Osteoarthritis | 0.2 | 0.2 | |
Osteoporosis | 1 | 0.5 | 1 |
Parkinson's Disease | 1.9 | 3.3 | -0.74 |
Polycystic ovary syndrome | 1.9 | 1.9 | |
Postural orthostatic tachycardia syndrome | 0.5 | 0.5 | |
Psoriasis | 1 | 0.6 | 0.67 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 2.8 | 2 | 0.4 |
Rosacea | 0.7 | -0.7 | |
Schizophrenia | 0.9 | 0.7 | 0.29 |
Sjögren syndrome | 0.5 | 0.5 | |
Sleep Apnea | 0.7 | 0.7 | |
Small Intestinal Bacterial Overgrowth (SIBO) | 0.9 | 0.9 | |
Stress / posttraumatic stress disorder | 1.4 | 0.8 | 0.75 |
Systemic Lupus Erythematosus | 2 | 1 | 1 |
Tourette syndrome | 1.1 | -1.1 | |
Type 1 Diabetes | 0.2 | 0.5 | -1.5 |
Type 2 Diabetes | 2.9 | 1.3 | 1.23 |
Ulcerative colitis | 4 | 0.7 | 4.71 |
Unhealthy Ageing | 1.6 | 0.2 | 7 |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.